$21.30
0.25 (+1.19%)
Pfizer, Inc. (NYSE:PFE)
CAPS Rating:
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
Pharmaceutical industry has been hit with downward pressure from products coming off-patent for the last few years.
They are sitting on 20 billion dollars in cash in case things get tough in the upcoming year. This cash could easily be used to buy a bio-tech firm as well.
41 consecutive years of increased dividends. There is plenty of incentive to wait for the next blockbuster drug to come from Pfizer. Healthcare is a trend that will never end.
This is a good play keeping future trends in mind because the baby boomer generation is getting older and healthcare demand and demand for new drugs in general will only increase. It is also interesting to consider the positive impact on sales both Obama and Hillary’s universal healthcare plans will have when implemented.
Undervalued, Unpopular & excellent dividends.